UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2021 | 2022-11-07 | Future report Set alerts | |
| Q2 2021 | 2022-08-11 | -0.19 | -0.19 |
| Q1 2021 | 2022-05-12 | -0.18 | -0.18 |
| Q4 2020 | 2022-03-29 | -0.20 | -0.20 |
| Q3 2020 | 2021-11-09 | -0.22 | -0.22 |
| Q2 2020 | 2021-08-12 | -0.12 | -0.12 |
| Q1 2020 | 2021-05-13 | -0.20 | -0.20 |
| Q4 2019 | 2021-03-30 | -0.19 | -0.19 |
| Q3 2019 | 2019-11-14 | -1.35 | -1.35 |
| Q2 2019 | 2019-08-13 | -0.03 | -0.03 |
| 2016-05-16 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-16 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Boost Price Target | Rodman & Renshaw | Buy | $6.50 to $7.50 |
| 2016-03-17 | Lower Price Target | FBR & Co. | Outperform | $7.00 to $6.00 |
| 2016-03-03 | Initiated Coverage | FBR & Co. | Outperform | $7.00 |
| 2015-11-16 | Lower Price Target | Roth Capital | Neutral | $2.75 to $2.50 |
| 2015-11-12 | Initiated Coverage | HC Wainwright | Buy | $6.50 |
| 2015-10-29 | Lower Price Target | Roth Capital | Neutral | $4.50 to $2.75 |
| 2015-07-21 | Lower Price Target | Roth Capital | Neutral | $6.75 to $4.50 |
| 2011-10-03 | Downgrade | Maxim Group | Buy to Hold | |
| 1970-01-01 |
| 2016-05-16 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-16 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Boost Price Target | Rodman & Renshaw | Buy | $6.50 to $7.50 |
| 2016-03-17 | Lower Price Target | FBR & Co. | Outperform | $7.00 to $6.00 |
| 2016-03-03 | Initiated Coverage | FBR & Co. | Outperform | $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CRMD 54 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| NOMURA HOLDINGS INC | 2.95M |
| Vanguard Group, Inc | 1.80M |
| BlackRock Inc. | 0.63M |
| BlackRock Institutional Trust Company, N.A. | 0.60M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.35M |
| BANK OF MONTREAL /CAN/ | 0.19M |
| STATE STREET CORP | 0.17M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.15M |
| BARCLAYS PLC | 0.14M |
| CITADEL ADVISORS LLC | 0.13M |
| MORGAN STANLEY | 0.12M |
| TWO SIGMA INVESTMENTS LLC | 0.12M |
| BlackRock Fund Advisors | 0.11M |
| HBK Sorce Advisory LLC | 73750 |
| NORTHERN TRUST CORP | 71264 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PHARMABIO DEVELOPMENT INC | 3.54% (778563) | CRMD / |
| Gelbfish Gary A. | 3.13% (687927) | CRMD / |
| Khan Mehmood | 1.82% (400000) | CRMD / PEP / |
| Kaplan Myron | 1.34% (294166) | CRMD / |
| MILBY RANDY Chief Operating Officer | 1.12% (246243) | CRMD / |
| Lefkowitz Steven W | 0.99% (217399) | CRMD / |
| TELLEZ CORA M | 0.83% (182371) | CRMD / HMSY / PPBI / |
| ELLISON RUSSELL H | 0.73% (160000) | ASMB / CRMD / |
| Baluch Khoso Chief Executive Officer | 0.55% (121207) | CRMD / |
| Houser Mark T. Chief Medical Officer | 0.24% (52832) | CRMD / |
| Cook Robert W. Chief Financial Officer | 0.23% (50000) | CRMD / IMNP / MELA / |
| Lefkowitz James | 0.18% (40272) | CRMD / MNDL / |
| Dillione Janet | 0.18% (39969) | CRMD / NUAN / |
| ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | 0.18% (38861) | CRMD / |
| Markvicka Taunia | 0.17% (37100) | CRMD / PCRX / |
| Duffy Matthew | 0.13% (28571) | CRMD / |
| Houghton John C. President and CEO | 0.08% (17328) | CRMD / |
| LENZ BRIAN Chief Financial Officer | 0.08% (17000) | ADMA / CRMD / |
| GEORGE MICHAEL W | 0.05% (10000) | CRMD / |
| HOFER TIMOTHY M Secretary | 0.04% (8425) | CRMD / |
UM